ZNF16 inhibitors represent a class of chemical compounds that interact with the zinc finger protein 16 (ZNF16), a type of transcription factor characterized by its zinc finger domains. ZNF16 is part of the larger family of zinc finger proteins, which play a critical role in binding DNA, RNA, or proteins, thereby influencing the regulation of gene expression. The inhibition of ZNF16 can modulate its role in cellular processes, particularly those related to transcriptional regulation. Zinc finger proteins typically function by recognizing specific DNA sequences through their zinc finger motifs, which consist of structural arrangements where a zinc ion stabilizes the fold of the protein. ZNF16, like other members of this family, may participate in various cellular pathways by binding to DNA and modulating the expression of target genes involved in cell growth, differentiation, and stress response. By inhibiting ZNF16, researchers can study the impact of this transcription factor on cellular gene expression and signal transduction pathways.
The design and development of ZNF16 inhibitors often focus on the precise disruption of the zinc finger domains, preventing the protein from binding to its target DNA sequences or interacting with other proteins. The structural specificity of these inhibitors can offer insights into the molecular mechanisms of ZNF16 activity, particularly in terms of how its inhibition alters the dynamics of transcriptional networks. Biochemically, ZNF16 inhibitors might utilize various approaches such as small molecules that chelate the zinc ion, modify the protein's conformational stability, or block critical binding interfaces. Such inhibitors can also help in mapping the biological role of ZNF16 in different contexts, including its interactions with other transcription factors, regulatory proteins, and chromatin remodeling complexes. Studying these inhibitors contributes significantly to understanding the complex regulatory networks governed by zinc finger proteins like ZNF16 and their broader implications in cellular biology and molecular genetics.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
TPEN | 16858-02-9 | sc-200131 | 100 mg | $127.00 | 10 | |
Zinc chelators like TPEN might indirectly affect ZNF16 by altering zinc availability, crucial for the function of zinc finger proteins. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
HDAC inhibitors such as Trichostatin A could indirectly influence ZNF16 by modifying chromatin structure and gene expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, may affect ZNF16 indirectly by altering gene expression patterns. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $246.00 $490.00 $536.00 | 16 | |
JAK/STAT inhibitors like Ruxolitinib could indirectly impact ZNF16 by modulating pathways involved in gene expression and cell signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002, a PI3K inhibitor, might affect ZNF16 indirectly by altering signaling pathways that intersect with DNA binding and gene regulation. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
Bromodomain inhibitors like JQ1 may influence ZNF16 indirectly by affecting transcription regulation and chromatin remodeling. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin, an mTOR inhibitor, might have indirect effects on ZNF16 through its role in cell growth and proliferation pathways. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $66.00 $153.00 | 16 | |
HSP90 inhibitors like 17-AAG could indirectly influence ZNF16 by affecting protein stability and function. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $290.00 $5572.00 $10815.00 $25000.00 $65000.00 $2781.00 | 63 | |
Splicing inhibitors such as Pladienolide B may indirectly impact ZNF16 by altering RNA splicing processes. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
α-Amanitin, an RNA polymerase inhibitor, could indirectly affect ZNF16 by impacting RNA synthesis and processing. | ||||||